Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain.
Tokarski, J.S., Zupa-Fernandez, A., Tredup, J.A., Pike, K., Chang, C., Xie, D., Cheng, L., Pedicord, D., Muckelbauer, J., Johnson, S.R., Wu, S., Edavettal, S.C., Hong, Y., Witmer, M.R., Elkin, L.L., Blat, Y., Pitts, W.J., Weinstein, D.S., Burke, J.R.(2015) J Biol Chem 290: 11061-11074
- PubMed: 25762719 
- DOI: 10.1074/jbc.M114.619502
- Primary Citation of Related Structures:  
4WOV - PubMed Abstract: 
Inhibition of signal transduction downstream of the IL-23 receptor represents an intriguing approach to the treatment of autoimmunity. Using a chemogenomics approach marrying kinome-wide inhibitory profiles of a compound library with the cellular activity against an IL-23-stimulated transcriptional response in T lymphocytes, a class of inhibitors was identified that bind to and stabilize the pseudokinase domain of the Janus kinase tyrosine kinase 2 (Tyk2), resulting in blockade of receptor-mediated activation of the adjacent catalytic domain ...